AU2002226000A1 - Injectable sustained release delivery system with loperamide - Google Patents

Injectable sustained release delivery system with loperamide

Info

Publication number
AU2002226000A1
AU2002226000A1 AU2002226000A AU2600002A AU2002226000A1 AU 2002226000 A1 AU2002226000 A1 AU 2002226000A1 AU 2002226000 A AU2002226000 A AU 2002226000A AU 2600002 A AU2600002 A AU 2600002A AU 2002226000 A1 AU2002226000 A1 AU 2002226000A1
Authority
AU
Australia
Prior art keywords
loperamide
delivery system
sustained release
release delivery
injectable sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002226000A
Inventor
Richard L. Dunn
David W Osborne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tolmar Therapeutics Inc
Original Assignee
Atrix Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atrix Laboratories Inc filed Critical Atrix Laboratories Inc
Publication of AU2002226000A1 publication Critical patent/AU2002226000A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
AU2002226000A 2000-11-13 2001-11-13 Injectable sustained release delivery system with loperamide Abandoned AU2002226000A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71082500A 2000-11-13 2000-11-13
US09/710,825 2000-11-13
PCT/US2001/047116 WO2002038185A2 (en) 2000-11-13 2001-11-13 Injectable sustained release delivery system with loperamide

Publications (1)

Publication Number Publication Date
AU2002226000A1 true AU2002226000A1 (en) 2002-05-21

Family

ID=24855703

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002226000A Abandoned AU2002226000A1 (en) 2000-11-13 2001-11-13 Injectable sustained release delivery system with loperamide

Country Status (2)

Country Link
AU (1) AU2002226000A1 (en)
WO (1) WO2002038185A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039729A1 (en) 2002-06-25 2005-03-09 Alza Corp SHORT-TERM DEPOSIT FORMULATIONS
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
DK1539101T3 (en) * 2002-07-31 2009-04-27 Alza Corp Injectable, multi-modal polymeric compositions and applications thereof
KR20050088288A (en) * 2002-11-06 2005-09-05 알자 코포레이션 Controlled release depot formulations
US7202259B2 (en) 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
CN1822816A (en) * 2003-05-30 2006-08-23 阿尔萨公司 Implantable elastomeric depot compositions and uses thereof
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
US20080319020A1 (en) 2005-11-21 2008-12-25 Purdue Pharma L.P. 4-Oxadiazolyl-Piperidine Compounds and Use Thereof
WO2008005371A2 (en) 2006-06-29 2008-01-10 Medtronic, Inc. Poly(orthoester) polymers, and methods of making and using same
PL2079485T3 (en) 2006-11-01 2012-12-31 Purdue Pharma Lp Phenylpropionamide compounds and the use thereof
WO2008153611A2 (en) 2007-05-25 2008-12-18 Qlt Usa, Inc. Sustained delivery formulations of risperidone compounds
US8956642B2 (en) 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
US8475823B2 (en) 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
WO2009148580A2 (en) * 2008-06-03 2009-12-10 Qlt Usa, Inc. Controlled release copolymer formulation with improved release kinetics
US10285936B2 (en) 2010-05-31 2019-05-14 Laboratorios Farmacéuticos Rovi, S.A. Injectable composition with aromatase inhibitor
US10335366B2 (en) 2010-05-31 2019-07-02 Laboratorios Farmacéuticos Rovi, S.A. Risperidone or paliperidone implant formulation
US10350159B2 (en) 2010-05-31 2019-07-16 Laboratories Farmacéuticos Rovi, S.A. Paliperidone implant formulation
US10463607B2 (en) 2010-05-31 2019-11-05 Laboratorios Farmaceutics Rofi S.A. Antipsychotic Injectable Depot Composition
HUE057236T2 (en) 2010-05-31 2022-04-28 Farm Rovi Lab Sa Compositions for injectable in-situ biodegradable implants
US10881605B2 (en) 2010-05-31 2021-01-05 Laboratorios Farmaceuticos Rovi, S.A. Methods for the preparation of injectable depot compositions
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
CA3114061A1 (en) * 2018-09-25 2020-04-02 Tolmar International, Ltd. Liquid polymer delivery system for extended administration of drugs
BR112022013784A2 (en) 2020-01-13 2022-10-11 Durect Corp DISTRIBUTION SYSTEMS FOR PROLONGED RELEASE DRUGS WITH REDUCED IMPURITIES AND RELATED METHODS
TW202313047A (en) 2021-09-21 2023-04-01 西班牙商禾霏藥品實驗室有限公司 Antipsychotic injectable depot composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175235A (en) * 1990-06-04 1992-12-29 Nova Pharmaceutical Corporation Branched polyanhydrides
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition

Also Published As

Publication number Publication date
WO2002038185A3 (en) 2003-01-16
WO2002038185A2 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
AU2002226000A1 (en) Injectable sustained release delivery system with loperamide
EP1248656B8 (en) Shear-sensitive injectable delivery system
SG98393A1 (en) Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
AU7333601A (en) Drug delivery management system
AU2001284835A1 (en) Self-regulating gasoline direct injection system
AU6213901A (en) Fuel delivery unit
AUPR602401A0 (en) Sustained release delivery system
AU2001283359A1 (en) Drug release (delivery system)
AU2002210894A1 (en) Sustained release delivery system and uses thereof
GB2352314B (en) Delivery system
GB0011066D0 (en) Delivery system
AU6254101A (en) Delivery receptable system
AUPR434401A0 (en) Fuel delivery system
AU2002222138A1 (en) Drug delivery system
GB0014898D0 (en) Delivery system
AU2002210580A1 (en) Drug delivery system
GB9914960D0 (en) Delivery system
GB0210014D0 (en) Fuel delivery system
GB0101866D0 (en) Fuel delivery system
AU2001238040A1 (en) Offer delivery system
GB9911706D0 (en) Sustained release delivery technology
AUPQ616800A0 (en) Secure delivery system
AUPR132800A0 (en) Fuel delivery system
GB0015570D0 (en) Fuel delivery system
GB0001935D0 (en) Delivery system